2005•Cancer Detection and PreventionRequires access

Suppression of 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis by pre-initiation treatment of rats with β-naphthoflavone coincides with decreased levels of the carcinogen-derived DNA adducts in the mammary gland

Danuta Malejka‐Giganti, Kristen K. Bennett, Sandra J. Culp, Frederick A. Beland, Hisashi Shinozuka, Robin Bliss

Open publisher page 11 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 11 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: DMBA, 7,12-Dimethylbenz[a]anthracene, Carcinogen, Internal medicine, Endocrinology, Mammary gland, Mammary tumor, Chemistry

Back to paper search Browse research topics Original source

Suppression of 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis by pre-initiation treatment of rats with β-naphthoflavone coincides with decreased levels of the carcinogen-derived DNA adducts in the mammary gland — Research Paper | ScholarLens